Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases.
Miyako Yuasa-Kawase （川瀬都）1), Daisaku Masuda （増田大作）1), Taiji Yamashita 1), Ryota Kawase 1), Hajime Nakaoka 1), Miwako Inagaki （稲垣美和子）1), Kazuhiro Nakatani （中谷和弘) 1), Kazumi Tsubakio-Yamamoto （山本和美）1), Tohru Ohama 1) 3), Akifumi Matsuyama 2), Makoto Nishida （西田誠） 1) 3), Masato Ishigami （石神眞人）4), Toshiharu Kawamoto 5), Issei Komuro （小室一成） 1), Shizuya Yamashita （山下静也） 1)
Source
1) Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine. 2) Department of Somatic Stem Cell Therapy, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation. 3) Health Care Center, Osaka University. 4) Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine. 5) Kure Heart Center, National Hospital Organization Kure Medical Center.
Funding
This work was supported by the following grants: a grant-in-aid for Scientific Research (No. 18659267) to S. Yamashita from the Minist of Education, Science, Sports and Culture in Japan; a grant from Mitsui Life Social Welfare Foundation to S. Yamashita; a Takeda Medical Researech Foundation Grant to S. Yamashita; and in part by the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) to A. Matsuyama and S. Yamashita.
Fig.2 (A is the same as C)
論文捏造＆研究不正
今話題の阪大循環器内科グループの論文：J Atheroscler Thromb. 2012;19(3):263-75. Fig.2A (RCA) と Fig.2C (RCIA) の写真が同一。https://www.jstage.jst.go.jp/article/jat/19/3/19_10603/_pdf …
UO 
0 件のコメント:
コメントを投稿